-
EP3103458
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3103458
| EP3103458 - NOVEL POLYNUCLEOTIDES AND METHODS FOR INHIBITING CANCER CELLS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 04.01.2019 Database last updated on 28.05.2024 | |
| Former | Examination is in progress Status updated on 20.04.2018 | ||
| Former | Request for examination was made Status updated on 23.06.2017 | ||
| Former | The application has been published Status updated on 11.11.2016 | Most recent event Tooltip | 04.01.2019 | Application deemed to be withdrawn | published on 06.02.2019 [2019/06] | Applicant(s) | For all designated states Chang Gung Memorial Hospital, Linkou No. 5, Fusing Street Guishan District Taoyuan City 33305 / TW | [2016/50] | Inventor(s) | 01 /
YU, John No.5, Fusing St. Guishan Dist. 33305 Taoyuan City / TW | 02 /
CHO, Huan-Chieh No.5, Fusing St. Guishan Dist. 33305 Taoyuan City / TW | 03 /
YU, Alice No.5, Fusing St. Guishan Dist. 33305 Taoyuan City / TW | [2016/50] | Representative(s) | Cabinet Becker et Associés 25, rue Louis le Grand 75002 Paris / FR | [2016/50] | Application number, filing date | 16174013.9 | 10.06.2016 | [2016/50] | Priority number, date | US201562174572P | 12.06.2015 Original published format: US 201562174572 P | US201562198290P | 29.07.2015 Original published format: US 201562198290 P | [2016/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3103458 | Date: | 14.12.2016 | Language: | EN | [2016/50] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 27.10.2016 | Classification | IPC: | A61K31/713, A61K31/05, A61K31/352, A61P35/00 | [2016/50] | CPC: |
C12N15/113 (EP,US);
A61K31/05 (EP,US);
A61K31/135 (EP,US);
A61K31/352 (EP,US);
A61K31/7105 (EP,US);
A61P35/00 (EP);
A61P43/00 (EP);
C12N2310/14 (EP,US);
C12N2310/531 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/30] |
| Former [2016/50] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | NEUARTIGE POLYNUKLEOTIDE UND VERFAHREN ZUR HEMMUNG VON KREBSZELLEN | [2016/50] | English: | NOVEL POLYNUCLEOTIDES AND METHODS FOR INHIBITING CANCER CELLS | [2016/50] | French: | NOUVEAUX POLYNUCLÉOTIDES ET PROCÉDÉS POUR INHIBER DES CELLULES CANCÉREUSES | [2016/50] | Examination procedure | 10.06.2016 | Date on which the examining division has become responsible | 13.06.2017 | Amendment by applicant (claims and/or description) | 13.06.2017 | Examination requested [2017/30] | 24.04.2018 | Despatch of a communication from the examining division (Time limit: M04) | 05.09.2018 | Application deemed to be withdrawn, date of legal effect [2019/06] | 02.10.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2019/06] | Fees paid | Renewal fee | 18.06.2018 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]CN103784962 (UNIV TSINGHUA GRADUATE SCHOOL) [X] 11-15 * abstract *; | [X]CN102836149 (INST BIOPHYSICS CN ACAD SCI) [X] 1-3,9 * abstract *; | [I]WO2011129427 (DAIICHI SANKYO CO LTD [JP], et al) [I] 4-8,10 * abstract * | [X] - SCHLACHTERMAN ALEXANDER ET AL, "Combined Resveratrol, Quercetin, and Catechin Treatment Reduces Breast Tumor Growth in a Nude Mouse Model", TRANSLATIONAL ONCOLOGY, NEOPLASIA PRESS, UNITED STATES, (20080301), vol. 1, no. 1, doi:10.1593/TLO.07100, ISSN 1944-7124, pages 19 - 27, XP002604473 [X] 1-3,9 * abstract * * page 20 - page 21 * DOI: http://dx.doi.org/10.1593/TLO.07100 | [X] - GARVIN S ET AL, "Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo", CANCER LETTERS, NEW YORK, NY, US, vol. 231, no. 1, ISSN 0304-3835, (20060108), pages 113 - 122, (20060108), XP027884049 [X] 1-3,9 * abstract * * page 115, column 7 * * page 116, column 5 * * page 118, column 3 - page 119, column 1 * | by applicant | US7416849 | US4938949 | WO9518863 | WO9617823 | US5459127 | WO9521931 | WO9625508 | - ALTSCHUL ET AL., J. MOL. BIOL, (1990), vol. 215, page 403 | - FEIGNER ET AL., PROC. NATL. ACAD. SCI. USA, (1987), vol. 84, pages 7413 - 7 | - MACKEY ET AL., PROC. NATL. ACAD. SCI. USA, (1988), vol. 85, pages 8027 - 31 | - ULMER ET AL., SCIENCE, (1993), vol. 259, pages 1745 - 8 | - PNAS, (2001), vol. 98, pages 13790 - 13795 | - NATURE, (2011), vol. 475, pages 106 - 109 | - HC CHO ET AL., "Identification of Tumorigenic Cells in KrasG12D-Induced Lung Adenocarcinoma", CANCER RES., (2011), vol. 71, pages 7250 - 7258 | - PNAS, (2010), vol. 107, pages 18511 - 18516 |